EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Ubiquitination in cancer: mechanisms and therapeutic opportunities

Susi Zhu, Xu Zhang, Waner Liu, Zhe Zhou, Siyu Xiong, Jie Li, Xiang Chen, Cong Peng iD

Cancer Communications · 2025-09 · 45 (9) · 1128-1161

DOI: 10.1002/cac2.70044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Communications, online erschienen am 19.06.2025. Verfasst von Susi Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China. Hauptthemen laut MEDLINE: Ubiquitination, Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 323 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of Hunan Province, the Program of Introducing Talents of Discipline to Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ubiquitination, a key post‐translational modification, plays an essential role in tumor biology by regulating fundamental cellular processes, such as metabolism and cell death. Additionally, it interacts with other post‐translational modifications, which are closely linked to tumorigenesis, tumor progression, the tumor microenvironment, and the response to therapeutic interventions. Recent advancements in understanding the ubiquitination mechanisms have led to significant breakthroughs, offering novel perspectives and strategies for diagnosing and treating tumors. Here, we provided an overview of how ubiquitination influences tumor biology, focusing on its roles in immune regulation, metabolism, and its interactions with other modifications. We also summarized the clinical potential of targeting E3 ubiquitin ligases and deubiquitinases as therapeutic strategies in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UbiquitinationNeoplasmsHumansTumor MicroenvironmentProtein Processing, Post-TranslationalUbiquitin-Protein LigasesAnimals

Stichwörter der Autor:innen

Ubiquitinationcell deathmetabolismtherapeutic opportunitiestumor microenvironment

Substanzen

Ubiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
  • National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
  • Furong Laboratory, Central South University, Changsha, Hunan, P. R. China.
  • Hunan Key Laboratory of Skin Cancer and Psoriasis, Human Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.

ORCID-Profile: Cong Peng

Förderung

  • National Natural Science Foundation of China
  • National Natural Science Foundation of Hunan Province
  • the Program of Introducing Talents of Discipline to Universities
  • The Fundamental Research Funds for the Central Universities of Central South University

Zitieren

APA

Zhu, S., Zhang, X., Liu, W., Zhou, Z., Xiong, S., Li, J., Chen, X., & Peng, C. (2025). Ubiquitination in cancer: mechanisms and therapeutic opportunities. Cancer Communications, 45(9), 1128-1161. https://doi.org/10.1002/cac2.70044

Vancouver

Zhu S, Zhang X, Liu W, Zhou Z, Xiong S, Li J, et al. Ubiquitination in cancer: mechanisms and therapeutic opportunities. Cancer Communications. 2025;45(9):1128-1161. doi:10.1002/cac2.70044

BibTeX
@article{Zhu2025,
  author = {Zhu, Susi and Zhang, Xu and Liu, Waner and Zhou, Zhe and Xiong, Siyu and Li, Jie and Chen, Xiang and Peng, Cong},
  title = {Ubiquitination in cancer: mechanisms and therapeutic opportunities},
  journal = {Cancer Communications},
  year = {2025},
  volume = {45},
  number = {9},
  pages = {1128--1161},
  doi = {10.1002/cac2.70044}
}
Kostenlos starten →